Simultaneous determination of plasma nicotine and cotinine by UHPLC-MS/MS in C57BL/6 mice and its application in a pharmacokinetic study.

PMID:31257625
Liu Y , Zhang D , Du J , Qin Y , Zhao Z , Shi Y , Mei S , Liu Y
Biomedical chromatography : BMC
Plasma concentrations of nicotine and its active metabolite cotinine are highly correlated with its biological effects. A UHPLC-MS/MS method was developed, validated, and applied for nicotine and cotinine analysis in mice plasma. Chromatographic separation was achieved on a BEH HILIC column by using acetonitrile (0.1% formic acid) and 10 mM ammonium formate as mobile phase. The gradient elution was performed at 0.4 mL/min with a run time of 3.6 min. The quantitative ion transition was m/z 163.1 > 130.0 for nicotine, m/z 177.1 > 80.0 for cotinine, and m/z 167.1 > 134.0 for nicotine-D (internal standard, IS). For both nicotine and cotinine, the calibration range was 5-500 ng/mL with 5 ng/mL as the lower limit of quantitation, and the intra-day and inter-day bias and imprecision were -4.61% to 12.00% and less than 11.12%. The IS normalized recovery was 90.62% to 98.95% for nicotine and 89.18% to 101.53% for cotinine, and the IS normalized matrix factor was 106.00% to 116.44% for nicotine, and 100.34% to 109.85% for cotinine. Both nicotine and cotinine were stable at conventional storing conditions. The validated method has been applied to a pharmacokinetic study in mice to calculate the pharmacokinetic parameters for both analytes.


Copyright(C) 2006 BIOIMPACT Co., Ltd. All Rights Reserved